CPSI 10Q 6.30.2013
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 10-Q
ý
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
 
 
For the quarterly period ended June 30, 2013.
 
 
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from            to            .
Commission file number: 000-49796
 
COMPUTER PROGRAMS AND SYSTEMS, INC.
(Exact Name of Registrant as Specified in Its Charter)
 
Delaware
 
74-3032373
(State or Other Jurisdiction of
Incorporation or Organization)
 
(I.R.S. Employer
Identification No.)
 
 
6600 Wall Street, Mobile, Alabama
 
36695
(Address of Principal Executive Offices)
 
(Zip Code)
(251) 639-8100
(Registrant’s Telephone Number, Including Area Code)
N/A
(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)
 
 
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ý    No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer
 
¨
  
Accelerated filer
 
ý
 
 
 
 
Non-accelerated filer
 
¨  (Do not check if a smaller reporting company)
  
Smaller reporting company
 
¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  ý
As of August 8, 2013, there were 11,080,062 shares of the issuer’s common stock outstanding.
 

1
Table of Contents

COMPUTER PROGRAMS AND SYSTEMS, INC.
Form 10-Q
(For the three and six months ended June 30, 2013)
INDEX
 
 
 
 
Item 1.
 
 
 
 
 
 
Item 2.
Item 3.
Item 4.
Item 1.
Item 1A.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.

2
Table of Contents

PART I
FINANCIAL INFORMATION
Item 1.
Financial Statements.
COMPUTER PROGRAMS AND SYSTEMS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS 
 
June 30, 2013
 
December 31, 2012
 
(Unaudited)
 
 
Assets
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
1,583,642

 
$
8,912,457

Investments
10,686,239

 
10,674,609

Accounts receivable, net of allowance for doubtful accounts of $1,055,000 and $1,124,000, respectively
18,783,001

 
19,704,767

Financing receivables, current portion, net
27,961,060

 
4,618,131

Inventories
1,795,356

 
1,682,008

Deferred tax assets
2,938,682

 
2,463,567

Prepaid income taxes
415,587

 
1,809,220

Prepaid expenses and other
913,342

 
1,081,421

Total current assets
65,076,909

 
50,946,180

Property and equipment
 
 
 
Land
2,848,276

 
2,848,276

Buildings and improvements
9,299,660

 
9,067,504

Maintenance equipment
2,071,230

 
2,588,452

Computer equipment
5,582,680

 
5,795,707

Leasehold improvements
4,376,083

 
3,067,756

Office furniture and equipment
3,472,045

 
2,845,548

Automobiles
341,387

 
314,905

 
27,991,361

 
26,528,148

Less accumulated depreciation
(7,931,813
)
 
(7,498,174
)
Property and equipment, net
20,059,548

 
19,029,974

Financing receivables
1,067,272

 
7,862,833

Total assets
$
86,203,729

 
$
77,838,987

Liabilities and Stockholders’ Equity
 
 
 
Current liabilities:
 
 
 
Accounts payable
$
2,844,443

 
$
2,980,174

Deferred revenue
9,650,245

 
7,452,612

Accrued vacation
3,827,871

 
3,506,106

Other accrued liabilities
5,699,520

 
4,521,773

Total current liabilities
22,022,079

 
18,460,665

Deferred tax liabilities
2,184,037

 
2,176,130

Stockholders’ equity:
 
 
 
Common stock, $0.001 par value; 30,000,000 shares authorized; 11,080,062 and 11,077,672 shares issued and outstanding
11,080

 
11,078

Additional paid-in capital
33,528,384

 
32,848,101

Accumulated other comprehensive income
13,919

 
27,693

Retained earnings
28,444,230

 
24,315,320

Total stockholders’ equity
61,997,613

 
57,202,192

Total liabilities and stockholders’ equity
$
86,203,729

 
$
77,838,987

The accompanying notes are an integral part of these financial statements.

3
Table of Contents

COMPUTER PROGRAMS AND SYSTEMS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)
 

 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2013
 
2012
 
2013
 
2012
Sales revenues:

 

 
 
 
 
System sales
$
22,376,682

 
$
17,828,593

 
$
43,098,667

 
$
34,903,111

Support and maintenance
17,737,916

 
16,878,896

 
35,414,777

 
33,544,821

Business management, consulting and managed IT services
13,146,746

 
11,023,600

 
24,296,407

 
21,772,564

Total sales revenues
53,261,344

 
45,731,089

 
102,809,851

 
90,220,496

Costs of sales:

 

 
 
 
 
System sales
13,083,461

 
12,679,266

 
26,334,039

 
24,578,510

Support and maintenance
7,160,027

 
6,659,555

 
14,412,884

 
13,526,275

Business management, consulting and managed IT services
7,541,263

 
6,253,519

 
14,467,394

 
12,709,519

Total costs of sales
27,784,751

 
25,592,340

 
55,214,317

 
50,814,304

Gross profit
25,476,593

 
20,138,749

 
47,595,534

 
39,406,192

Operating expenses:

 

 
 
 
 
Sales and marketing
4,134,897

 
3,640,828

 
7,710,614

 
7,281,288

General and administrative
8,193,506

 
6,572,601

 
16,627,562

 
13,200,205

Total operating expenses
12,328,403

 
10,213,429

 
24,338,176

 
20,481,493

Operating income
13,148,190

 
9,925,320

 
23,257,358

 
18,924,699

Other income:

 

 
 
 
 
Interest income
136,985

 
189,355

 
273,299

 
348,491

Total other income
136,985

 
189,355

 
273,299

 
348,491

Income before taxes
13,285,175

 
10,114,675

 
23,530,657

 
19,273,190

Income taxes
4,799,542

 
1,853,378

 
8,101,302

 
5,362,843

Net income
$
8,485,633

 
$
8,261,297

 
$
15,429,355

 
$
13,910,347

Net income per share—basic
$
0.77

 
$
0.75

 
$
1.39

 
$
1.26

Net income per share—diluted
$
0.77

 
$
0.75

 
$
1.39

 
$
1.26

Weighted average shares outstanding

 

 
 
 
 
Basic
11,080,062

 
11,063,529

 
11,079,235

 
11,063,374

Diluted
11,080,062

 
11,063,529

 
11,079,235

 
11,063,374

Dividends declared per share
$
0.51

 
$
0.46

 
$
1.02

 
$
0.92


The accompanying notes are an integral part of these financial statements.


4
Table of Contents

COMPUTER PROGRAMS AND SYSTEMS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
 


 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2013
 
2012
 
2013
 
2012
Net income
$
8,485,633

 
$
8,261,297

 
$
15,429,355

 
$
13,910,347

Other comprehensive income(loss), net of tax
 
 
 
 
 
 
 
Unrealized gain(loss) on investments available for sale, net of tax
(17,517
)
 
(10,825
)
 
(13,774
)
 
15,591

Total other comprehensive income(loss), net of tax
(17,517
)
 
(10,825
)
 
(13,774
)
 
15,591

Comprehensive income
$
8,468,116

 
$
8,250,472

 
$
15,415,581

 
$
13,925,938


The accompanying notes are an integral part of these financial statements.

5
Table of Contents

COMPUTER PROGRAMS AND SYSTEMS, INC.
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (Unaudited)
 
 
Common
Shares
 
Common
Stock
 
Additional
Paid-in
Capital
 
Accumulated
Other
Comprehensive
Income
 
Retained
Earnings
 
Total
Stockholders’
Equity
Balance at December 31, 2012
11,077,672

 
$
11,078

 
$
32,848,101

 
$
27,693

 
$
24,315,320

 
$
57,202,192

Net income
—

 
—

 
—

 
—

 
15,429,355

 
15,429,355

Unrealized loss on investments held for sale, net of tax
—

 
—

 
—

 
(13,774
)
 
—

 
(13,774
)
Issuance of restricted stock
2,390

 
2

 
(2
)
 
—

 
—

 
—

Stock-based compensation
—

 
—

 
703,894

 
—

 
—

 
703,894

Dividends
—

 
—

 
—

 
—

 
(11,300,445
)
 
(11,300,445
)
Income tax benefit from restricted stock dividends
—

 
—

 
31,989

 
—

 
—

 
31,989

Deficient tax benefit from restricted stock
—

 
—

 
(55,598
)
 
—

 
—

 
(55,598
)
Balance at June 30, 2013
11,080,062

 
$
11,080

 
$
33,528,384

 
$
13,919

 
$
28,444,230

 
$
61,997,613

The accompanying notes are an integral part of these financial statements.

6
Table of Contents

COMPUTER PROGRAMS AND SYSTEMS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
 
 
Six Months Ended June 30,
 
2013
 
2012
Operating Activities
 
 
 
Net income
$
15,429,355

 
$
13,910,347

Adjustments to net income:
 
 
 
Provision for bad debt
1,647,291

 
234,735

Deferred taxes
(459,131
)
 
(95,674
)
Stock based compensation
703,894

 
614,779

Deficient tax benefit from restricted stock
55,598

 
96,934

Income tax benefit from restricted stock dividends
(31,989
)
 
(32,404
)
Depreciation
1,717,676

 
1,666,838

Changes in operating assets and liabilities:
 
 
 
Accounts receivable
660,373

 
954,546

Financing receivables
(17,933,266
)
 
(5,020,792
)
Inventories
(113,348
)
 
(326,747
)
Prepaid expenses and other
168,079

 
(751,994
)
Accounts payable
(135,731
)
 
316,885

Deferred revenue
2,197,633

 
846,067

Other liabilities
1,499,512

 
(563,099
)
Prepaid income taxes/income taxes payable
1,370,024

 
(308,679
)
Net cash provided by operating activities
6,775,970

 
11,541,742

Investing Activities
 
 
 
Purchases of property and equipment
(2,747,250
)
 
(1,671,947
)
Purchases of investments
(33,481
)
 
(1,072,303
)
Net cash used in investing activities
(2,780,731
)
 
(2,744,250
)
Financing Activities
 
 
 
Dividends paid
(11,300,445
)
 
(10,178,163
)
Deficient tax benefit from restricted stock
(55,598
)
 
(96,934
)
Income tax benefit from restricted stock dividends
31,989

 
32,404

Net cash used in financing activities
(11,324,054
)
 
(10,242,693
)
Decrease in cash and cash equivalents
(7,328,815
)
 
(1,445,201
)
Cash and cash equivalents at beginning of period
8,912,457

 
6,664,482

Cash and cash equivalents at end of period
$
1,583,642

 
$
5,219,281

Supplemental disclosure of cash flow information
 
 
 
Cash paid for interest
$
—

 
$
—

Cash paid for income taxes, net of refund
$
7,092,908

 
$
5,755,951

Reclassification of inventory to property and equipment
$
—

 
$
265,741

Write-off of fully depreciated assets
$
1,222,325

 
$
8,687,631



The accompanying notes are an integral part of these financial statements.

7
Table of Contents

COMPUTER PROGRAMS AND SYSTEMS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
1.     BASIS OF PRESENTATION
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and include all adjustments that, in the opinion of management, are necessary for a fair presentation of the results of the periods presented. All such adjustments are considered of a normal recurring nature. Quarterly results of operations are not necessarily indicative of annual results.
Certain footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements of Computer Programs and Systems, Inc. ("CPSI" or the "Company") for the year ended December 31, 2012 and the notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012.
Principles of Consolidation
The condensed consolidated financial statements of CPSI include the accounts of TruBridge, LLC ("TruBridge"), a wholly-owned subsidiary of CPSI. All significant intercompany balances and transactions have been eliminated.
Reclassifications
With the formation of TruBridge in January 2013 as a wholly-owned subsidiary of the Company focusing exclusively on providing business management, consulting and managed information technology ("IT") services to rural and community healthcare organizations, the Company's presentation of certain revenues and related costs of sales within its Condensed Consolidated Statements of Income was changed, as follows:
•
The Company's consulting and managed IT services revenues and related costs of sales are now included under the caption "Business management, consulting and managed IT services" within the accompanying Condensed Consolidated Statements of Income. These amounts were formerly included as a component of "Support and maintenance" within the Condensed Statements of Income.
•
The former captioned item, "Business management services," within the Condensed Statements of Income has been changed to "Business management, consulting and managed IT services" to reflect the additional revenue streams included under the recaptioned item as a result of the aforementioned reclassifications.
These reclassifications had no effect on previously reported total sales revenues, total costs of sales, gross profit, operating income, income before taxes or net income.
Amounts presented for the three and six months ended June 30, 2012 have been reclassified to conform to the current presentation. The following table provides the amounts reclassified for the three and six months ended June 30, 2012:
 
Three months ended June 30, 2012
 
Six Months Ended June 30, 2012
Sales revenues:
 
 
 
Support and maintenance
$
(1,517,914
)
 
$
(2,988,609
)
Business management, consulting and managed IT services
$
1,517,914

 
$
2,988,609

Costs of sales:
 
 
 
Support and maintenance
$
(854,043
)
 
$
(1,656,090
)
Business management, consulting and managed IT services
$
854,043

 
$
1,656,090





8
Table of Contents

2.     REVENUE RECOGNITION
The Company recognizes revenue in accordance with accounting principles generally accepted in the United States of America, principally those required by the Software topic and Revenue Recognition subtopic of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (the “Codification”) and those prescribed by the SEC.
The Company's revenue is generated from three sources:
•
System Sales - the sale of information systems, which includes perpetual software licenses, conversion, installation and training services, hardware and peripherals;
•
Support and Maintenance - the provision of system support services, which includes software application support, hardware maintenance, continuing education, "Software as a Service" (or "SaaS") services, and forms and supplies; and
•
Business Management, Consulting and Managed IT Services - the provision of business management services, which includes electronic billing, statement processing, payroll processing, accounts receivable management, contract management and insurance services, as well as Internet service provider ("ISP") services and consulting and managed IT services (collectively, "other professional IT services").
System Sales, Software Application Support, and Hardware Maintenance
The Company enters into contractual obligations to sell hardware, perpetual software licenses, conversion, installation and training services, and support and maintenance services. On average, the Company is able to complete a system installation in three to four weeks. The methods employed by the Company to recognize revenue, which are discussed by element below, achieve results materially consistent with the provisions of Accounting Standards Update (“ASU”) 2009-13, Multiple-Deliverable Revenue Arrangements, due to the relatively short period during which there are multiple undelivered elements, the relatively small amount of non-software related elements in the system sale arrangements, and the limited number of contracts in-process at the end of each reporting period. The Company recognizes revenue on the elements noted above as follows:
•
Software application support and hardware maintenance – We have established vendor-specific objective evidence (“VSOE”) of the fair value of our software application support and hardware maintenance services by reference to the price our customers are required to pay for the services when sold separately via renewals. Support and maintenance revenue is recognized on a straight-line basis over the term of the maintenance contract, which is generally three to five years.
•
Hardware – We recognize revenue for hardware upon shipment. The selling price of hardware is based on management’s best estimate of selling price, which consists of cost plus a targeted margin.
•
Software licenses and installation and training – The selling price of software licenses and installation and training is based on management’s best estimate of selling price. In determining management’s best estimate of selling price, we consider the following: (1) competitor pricing, (2) supply and demand of installation staff, (3) overall economic conditions, and (4) our pricing practices as they relate to discounts. With the exception of certain arrangements with extended payment terms that were entered into in 2012 and that are not comparable to our historical and current arrangements (see Note 8), the method of recognizing revenue for the perpetual license of the associated modules included in the arrangement, and the related installation and training services over the term the services are performed, is on a module by module basis as the respective installation and training for each specific module is completed, as this is representative of the pattern of provision of these services.
SaaS, ISP, and Other Professional IT Services
The Company accounts for SaaS services in accordance with the requirements of the Hosting Arrangement section under the Software topic and Revenue Recognition subtopic of the Codification. The Codification states that the software elements of SaaS services should not be accounted for as a hosting arrangement “if the customer has the contractual right to take possession of the software at any time during the hosting period without significant penalty and it is feasible for the customer to either run the software on its own hardware or contract with another party unrelated to the vendor to host the software.” Each SaaS contract entered into by the Company includes a system purchase and buyout clause, and this clause specifies the total amount of the system buyout. In addition, a clause is included in the contract which states that should the system be bought out by the customer, the customer would be required to enter into a general support agreement (for post-contract support services) for the remainder of the original SaaS term. Accordingly, the Company has concluded that SaaS

9
Table of Contents

customers do not have the right to take possession of the system without significant penalty (i.e., the purchase price of the system), resulting in the determination that these contracts are service contracts for which revenue is recognized when the services are performed.
The Company will occasionally provide ISP and other professional IT services. We consider these services to be non-software elements. The selling price of these services is based on third-party evidence of selling price of similar services. Revenue from this element is recognized as the services are performed.
Business Management Services
Business management services consist of electronic billing services, statement processing services, payroll processing, accounts receivable management services, contract management and insurance services. While business management service arrangements are contracts separate from the system sale and support and maintenance contracts, these contracts are sometimes executed within a short time frame of each other. The selling price of these services is based on VSOE of fair value by reference to the rate our customers renew as well as the rate at which the services are sold to customers when the business management services agreement is not executed within a short time frame. Because the pricing is transaction based (per unit pricing), customers are billed and revenue recognized as services are performed based on transaction levels.
3.     OTHER ACCRUED LIABILITIES
Other accrued liabilities are comprised of the following:
 
June 30, 2013
 
December 31, 2012
Salaries and benefits
$
2,829,513

 
$
2,155,435

Commissions
832,095

 
716,087

Self-insurance reserves
670,500

 
633,700

Unrecognized tax benefit
838,905

 
744,705

Other
528,507

 
271,846

 
$
5,699,520

 
$
4,521,773

4.     INVESTMENTS
The Company accounts for investments in accordance with FASB Codification topic, Investments – Debt and Equity Securities. Accordingly, investments are classified as available-for-sale securities and are reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of stockholders’ equity. The Company’s management determines the appropriate classification of investments in fixed income securities at the time of acquisition and re-evaluates the classification at each balance sheet date. An average cost method is used for purposes of determining the cost of investments sold.
Investments are comprised of the following at June 30, 2013:
 

Amortized
Cost

Unrealized
Gains

Unrealized
Losses

Fair
Value
Short-term investments (cash and accrued income)
$
2,139,002

 
$
—

 
$
—


$
2,139,002

Obligations of U.S. Treasury, U.S. government corporations and agencies
3,299,854

 
626

 
1,166


3,299,314

Mortgaged-backed securities
84,337

 
3,223

 
—


87,560

Corporate bonds
5,140,228

 
23,848

 
3,713


5,160,363


$
10,663,421


$
27,697


$
4,879


$
10,686,239


10
Table of Contents

Shown below are the amortized cost and estimated fair value of securities with fixed maturities at June 30, 2013, by contract maturity date. Actual maturities may differ from contractual maturities because issuers of certain securities retain early call or prepayment rights.
 
 
Amortized
Cost
 
Fair
Value
Due in 2013
$
3,900,139

 
$
3,905,119

Due in 2014
4,139,201

 
4,149,387

Due in 2015
2,389,826

 
2,395,784

Due in 2016
149,918

 
148,389

Due thereafter
84,337

 
87,560

 
$
10,663,421

 
$
10,686,239

Investments were comprised of the following at December 31, 2012:
 
 
Amortized
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair
Value
Short-term investments (cash and accrued income)
$
449,420

 
$
—

 
$
—

 
$
449,420

Obligations of U.S. Treasury, U.S. government corporations and agencies
2,381,313

 
1,031

 
565

 
2,381,779

Mortgaged-backed securities
93,458

 
2,146

 
—

 
95,604

Corporate bonds
7,705,914

 
53,236

 
11,344

 
7,747,806

 
$
10,630,105

 
$
56,413

 
$
11,909

 
$
10,674,609

The following table shows the Company’s investments’ gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities have been in a continuous loss position, at June 30, 2013 and December 31, 2012, respectively:
 
At June 30, 2013
 
Less than 12 Months
 
12 Months or More
 
Total
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
Obligations of U.S. Treasury, U.S. government corporations and agencies
$
1,622,979

 
$
1,166

 
$
—

 
$
—

 
$
1,622,979

 
$
1,166

Corporate bonds
388,399

 
3,264

 
312,293

 
449

 
700,692

 
3,713

 
$
2,011,378

 
$
4,430

 
$
312,293

 
$
449

 
$
2,323,671

 
$
4,879

 
At December 31, 2012
 
Less than 12 Months
 
12 Months or More
 
Total
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
Obligations of U.S. Treasury, U.S. government corporations and agencies
$
1,649,980

 
$
565

 
$
—

 
$
—

 
$
1,649,980

 
$
565

Corporate bonds
243,612

 
9,800

 
668,748

 
1,544

 
912,360

 
11,344

 
$
1,893,592

 
$
10,365

 
$
668,748

 
$
1,544

 
$
2,562,340

 
$
11,909

Our investment portfolio, including those securities in unrealized loss positions at June 30, 2013, is comprised almost entirely of investment-grade corporate and government debt securities. The Company does not intend to sell the investments that are in an unrealized loss position, and it is not likely that the Company will be required to sell any investments before recovery of their amortized cost basis. As a result, the Company has determined that the unrealized losses are deemed to be temporary impairments as of June 30, 2013. The Company believes that the unrealized losses generally are caused by liquidity discounts and increases in risk premiums required by market participants rather than an adverse change in cash flows or a fundamental weakness in the credit quality of the issuer or underlying assets.

11
Table of Contents

5.     NET INCOME PER SHARE
The Company presents both basic and diluted earnings per share (“EPS”) amounts. Basic EPS is calculated by dividing net income by the weighted average number of common shares outstanding during the period presented. Diluted EPS amounts are based upon the weighted average number of common and common equivalent shares outstanding during the period presented. There were no dilutive shares outstanding for the three and six month periods ended June 30, 2013 or June 30, 2012.
6.     INCOME TAXES
The Company accounts for income taxes in accordance with FASB’s Codification topic, Income Taxes. Deferred income taxes arise from the temporary differences in the recognition of income and expenses for tax purposes. A valuation allowance is established when the Company believes that it is more likely than not that some portion of its deferred tax assets will not be realized. Deferred tax assets and liabilities are comprised of the following at June 30, 2013 and December 31, 2012:
 
June 30,
2013
 
December 31,
2012
Deferred tax assets:
 
 
 
Accounts receivable
$
1,015,126

 
$
696,672

Accrued vacation
1,492,870

 
1,367,381

Stock-based compensation
188,374

 
351,850

Accrued liabilities
430,685

 
432,707

Total deferred tax assets
$
3,127,055

 
$
2,848,610

Deferred tax liabilities:
 
 
 
Other comprehensive income
$
8,897

 
$
16,974

Depreciation
2,363,513

 
2,544,199

Total deferred tax liabilities
$
2,372,410

 
$
2,561,173

Significant components of the Company’s income tax provision in the Condensed Consolidated Statements of Income for the six months ended June 30 are as follows:
 
2013
 
2012
Current provision:
 
 
 
Federal
$
7,193,983

 
$
5,020,474

State
1,366,450

 
438,043

Deferred provision:

 

Federal
(412,040
)
 
(85,859
)
State
(47,091
)
 
(9,815
)
Total income tax provision
$
8,101,302

 
$
5,362,843

The difference between income taxes at the U. S. federal statutory income tax rate of 35% and those reported in the Condensed Consolidated Statements of Income for the six months ended June 30 is as follows:
 
2013
 
2012
Income taxes at U. S. Federal statutory rate
$
8,235,730

 
$
6,745,616

Provision-to-return adjustments
—

 
(1,815,067
)
State income tax, net of federal tax effect
841,102

 
824,850

Domestic production activities deduction
(741,904
)
 
(446,268
)
Tax credits
(376,800
)
 
—

Other
143,174

 
53,712

Total income tax provision
$
8,101,302

 
$
5,362,843



12
Table of Contents

The provision-to-return adjustments presented above for the six months ended June 30, 2012 are primarily related to differences between the Domestic Production Activities Deduction reported on the 2011 federal income tax return and amounts previously estimated. As a result of these provision-to-return adjustments, recorded during the second quarter of 2012, our effective tax rates for the three and six months ended June 30, 2013 are significantly higher than same prior year periods. Our effective tax rates for the three and six months ended June 30, 2013 were 36.1% and 34.4%, respectively, compared to 18.3% and 27.8% for the three and six months ended June 30, 2012.
The Company had unrecognized tax benefits of $838,905 related to uncertain tax positions as of June 30, 2013 under the provisions of FASB Codification topic, Income Taxes, which is recorded in other accrued liabilities on the Condensed Consolidated Balance Sheet. No accrued interest or penalties for such positions is recorded. The federal returns for the tax years 2004, 2005, and 2006 are currently under examination by the Internal Revenue Service, primarily in relation to research credits and Domestic Production Activities Deduction amounts claimed on those returns, as amended, by the Company. The federal returns for tax years 2007 through 2011 remain open to examination, and the tax years 2006 through 2011 remain open to examination by other taxing jurisdictions to which the Company is subject.
7.     STOCK-BASED COMPENSATION AND EMPLOYEE INCENTIVE PROGRAMS
Stock-based compensation cost is measured at the grant date based on the fair value of the award, and is recognized as an expense over the employee’s or non-employee director’s requisite service period.
The following table shows total stock-based compensation expense for the three and six months ended June 30, 2013 and 2012, included in the Condensed Consolidated Statements of Income:
 
 
Three Months Ended
 
Six Months Ended
 
June 30, 2013
 
June 30, 2012
 
June 30, 2013
 
June 30, 2012
Costs of sales
$
114,999

 
$
114,999

 
$
229,998

 
$
229,998

Operating expenses
240,421

 
194,779

 
473,896

 
384,781

Pre-tax stock-based compensation expense
355,420

 
309,778

 
703,894

 
614,779

Less: income tax effect
138,614

 
120,813

 
274,519

 
239,764

Net stock-based compensation expense
$
216,806

 
$
188,965

 
$
429,375

 
$
375,015

2005 Restricted Stock Plan
On April 18, 2011, the Compensation Committee of the Board of Directors approved the grant of a total of 100,346 shares of restricted stock, effective April 18, 2011, to certain executive officers of the Company. The grant date fair value was $60.79 per share. Under the terms of the restricted stock award agreements with the executive officers, the shares of restricted stock are scheduled to vest in five equal annual installments commencing on April 18, 2012 and each April 18 thereafter, assuming that the recipient of the award continues to serve as an executive officer of the Company on each applicable vesting date. Compensation expense for this grant is being recognized on a straight-line basis over five years.
On October 31, 2012, the Compensation Committee of the Board of Directors approved the grant of a total of 12,292 shares of restricted stock, effective October 31, 2012, to two executive officers of the Company. The grant date fair value was $48.81 per share. Under the terms of the restricted stock award agreements with the executive officers, the shares of restricted stock are scheduled to vest in five equal annual installments commencing on October 31, 2013 and each October 31 thereafter, assuming that the recipient of the award continues to serve as an executive officer of the Company on each applicable vesting date. Compensation expense for this grant is being recognized on a straight-line basis over five years.
2012 Restricted Stock Plan for Non-Employee Directors
On June 18, 2012, the Compensation Committee of the Board of Directors approved the grant of 2,160 shares of restricted stock, effective June 18, 2012, to the five non-employee directors of the Company under the Company’s 2012 Restricted Stock Plan for Non-Employee Directors. The grant date fair value was $55.55 per share. Under the terms of the restricted stock award agreements with the non-employee directors, the shares of restricted stock are scheduled to vest on the third anniversary of the date of grant, assuming that the recipient of the grant continues to serve as a director of the Company on the vesting date. Compensation expense for this grant is being recognized on a straight-line basis over three years.
On March 4, 2013, the Compensation Committee of the Board of Directors approved the grant of a total of 2,390 shares of restricted stock, effective March 4, 2013, to the five non-employee directors of the Company under the Company's 2012 Restricted Stock Plan for Non-Employee Directors. The grant date fair value was $52.32 per share. Under the terms of the restricted stock award agreements with the non-employee directors, the shares of restricted stock are scheduled to vest on

13
Table of Contents

the third anniversary of the date of grant, assuming that the recipient of the grant continues to serve as a director of the Company on the vesting date. Compensation expense for this grant is being recognized on a straight-line basis over three years.
A summary of activity under the 2005 Restricted Stock Plan and the 2012 Restricted Stock Plan for Non-Employee Directors (the “Plans”) for the six months ended June 30, 2013 and 2012 is as follows:
 
Six Months Ended June 30, 2013
 
Six Months Ended June 30, 2012
 
Shares
 
Weighted-Average
Grant-Date
Fair Value
 
Shares
 
Weighted-Average
Grant-Date
Fair Value
Nonvested stock outstanding at beginning of period
94,729

 
$
59.12

 
100,346

 
$
60.79

Granted
2,390

 
52.32

 
2,160

 
55.55

Vested
(20,069
)
 
60.79

 
(20,069
)
 
60.79

Nonvested stock outstanding at end of period
77,050

 
$
58.47

 
82,437

 
$
60.65

As of June 30, 2013, there was $4,118,974 of unrecognized compensation cost related to non-vested restricted stock granted under the Plans.
2013 Incentive Program
On March 4, 2013, the Board of Directors, upon the recommendation of the Compensation Committee, adopted a short-term incentive program for 2013 for the executive officers of the Company, other than executive officers earning any commission-based compensation (the “2013 Incentive Program”). Under the 2013 Incentive Program, certain executive officers of the Company were granted a short-term incentive cash bonus opportunity based on the achievement of a specified level of financial performance, specifically the Company’s earnings before interest, income taxes, depreciation and amortization (“EBITDA”) in 2013 (“2013 EBITDA”) compared to the Company’s EBITDA in 2012 (“2012 EBITDA”).
Participants in the 2013 Incentive Program will receive 100% of their target award amount if the Company’s 2013 EBITDA is 105% of 2012 EBITDA, 75% of the target award amount if the Company achieves a minimum threshold level of performance (2013 EBITDA reaching 95% of 2012 EBITDA), and a maximum of 150% of the target award amount for a maximum level of performance (2013 EBITDA equaling or exceeding 130% of 2012 EBITDA). No payments are to be made for performance below the specified threshold amount. Payouts between the threshold and maximum are calculated by the Compensation Committee using the interpolation process described in the 2013 Incentive Program. The Compensation Committee may make adjustments to the terms and conditions of, and the criteria included in, awards under the 2013 Incentive Program in recognition of unusual or nonrecurring events affecting a participant or the Company, or the financial statements of the Company, or in certain other instances specified in the 2013 Incentive Program.
Awards earned under the 2013 Incentive Program are to be paid solely in cash. In addition, awards pursuant to the 2013 Incentive Program are subject to recovery or adjustments by the Company in certain circumstances in which the operating results on which payment was based are restated or otherwise adjusted or in the event that a participant’s conduct is not in good faith and materially disrupts, damages, impairs or interferes with the business of the Company.
8.     FINANCING RECEIVABLES
Short-Term Payment Plans
The Company has sold information and patient care systems to certain healthcare providers under short-term payment plans, which typically have expected terms from 3 to 12 months. These receivables, included in the current portion of financing receivables, were comprised of the following on June 30, 2013 and December 31, 2012:
 
 
June 30,
2013
 
December 31,
2012
Short-term payment plans, gross
$
26,744,807

 
$
448,487

Less: allowance for losses
(1,337,240
)
 
(22,424
)
Less: unearned income
—

 
—

Short-term payment plans, net
$
25,407,567

 
$
426,063


14
Table of Contents

The significant increase in amounts due under short-term payment plans from December 31, 2012 to June 30, 2013 is due to those factors described under the caption "Second Generation Meaningful Use Installment Plans" below.
Sales-Type Leases
Additionally, the Company leases its information and patient care systems to certain healthcare providers under sales-type leases expiring in various years through 2017. These receivables typically have terms from two to five years, bear interest at various rates, and are usually collateralized by a security interest in the underlying assets. Since the Company has a history of successfully collecting amounts due under the original payment terms of these extended payment arrangements without making any concessions to its customers, the Company satisfies the requirement for revenue recognition. The Company’s history with these types of extended payment term arrangements supports management’s assertion that revenues are fixed and determinable and probable of collection.
The components of these lease receivables were as follows on June 30, 2013 and December 31, 2012:
 
June 30,
2013
 
December 31,
2012
Sales-type leases, gross
4,315,692

 
13,665,300

Less: allowance for losses
(210,649
)
 
(639,891
)
Less: unearned income
(484,278
)
 
(970,508
)
Sales-type leases, net
$
3,620,765

 
$
12,054,901

The significant decrease in amounts due under sales-type leases from December 31, 2012 to June 30, 2013 is due to those factors described under the caption "Second Generation Meaningful Use Installment Plans" below.
Future minimum lease payments to be received subsequent to June 30, 2013 are as follows:
 
2013
$
1,934,219

2014
1,720,102

2015
540,459

2016
72,000

2017
48,912

Thereafter
—

 
 
Total minimum lease payments to be received
4,315,692

Less unearned income
(484,278
)
 
 
Net leases receivable
$
3,831,414

 
 
Credit Quality of Financing Receivables and Allowance for Credit Losses
The following table is a roll-forward of the allowance for financing credit losses for the year ended December 31, 2012 and six months ended June 30, 2013:
 
Beginning
Balance
 
Provision
 
Charge-offs
 
Recoveries
 
Ending
Balance
December 31, 2012
$
447,321

 
$
214,994

 
$
—

 
$
—

 
$
662,315

June 30, 2013
$
662,315

 
$
1,385,898

 
$
(500,324
)
 
$
—

 
$
1,547,889

The Company’s financing receivables are comprised of a single portfolio segment, as the balances are all derived from short-term payment plan arrangements and sales-type leasing arrangements within our target market of rural and community hospitals. The Company evaluates the credit quality of its financing receivables based on a combination of factors, including, but not limited to, customer collection experience, economic conditions, the customer’s financial condition, and known risk characteristics impacting the respective customer base of rural and community hospitals, the most notable of which relate to enacted and potential changes in Medicare and Medicaid reimbursement rates as rural and community hospitals typically generate a significant portion of their revenues and related cash flows from beneficiaries of these programs. In addition to specific account identification, the Company utilizes historical collection experience to establish the allowance for credit losses. Financing receivables are written off only after the Company has exhausted all

15
Table of Contents

collection efforts. The Company has been successful collecting its financing receivables and considers the credit quality of such arrangements to be good, especially as the underlying assets act as collateral for the receivables.
Customer payments are considered past due if a scheduled payment is not received within contractually agreed upon terms. To facilitate customer collection and credit monitoring efforts, financing receivable amounts are invoiced and reclassified to trade accounts receivable when they become due, with all invoiced amounts placed on nonaccrual status. As a result, all past due amounts related to the Company’s financing receivables are included in trade accounts receivable in the accompanying Condensed Consolidated Balance Sheets. The following is an analysis of the age of financing receivables amounts (excluding short-term payment plans) that have been reclassified to trade accounts receivable and were past due as of June 30, 2013 and December 31, 2012:
 
 
1 to 90 Days
Past Due
 
91 to 180 Days
Past Due
 
181 + Days
Past Due
 
Total
Past Due
June 30, 2013
$
800,323

 
$
160,894

 
$
52,146

 
$
1,013,363

December 31, 2012
$
1,108,108

 
$
297,812

 
$
301,896

 
$
1,707,816

From time to time, the Company may agree to alternative payment terms outside of the terms of the original financing receivable agreement due to customer difficulties in achieving the original terms. In general, such alternative payment arrangements do not result in a re-aging of the related receivables. Rather, payments pursuant to any alternative payment arrangements are applied to the already outstanding invoices beginning with the oldest outstanding invoices as the payments are received.
Because amounts are reclassified to trade accounts receivable when they become due, there are no past due amounts included within the financing receivables or the financing receivables, current portion, net amounts in the accompanying Condensed Consolidated Balance Sheets.
The Company utilizes an aging of trade accounts receivable as the primary credit quality indicator for its financing receivables, which is facilitated by the reclassification of customer payment amounts to trade accounts receivable when they become due. The table below categorizes customer financing receivable balances (excluding short term payment plans), none of which are considered past due, based on the age of the oldest payment outstanding that has been reclassified to trade accounts receivable:
 
 
June 30,
2013
 
December 31,
2012
Customer balances with amounts reclassified to trade accounts receivable that are:
 
 
 
1 to 90 Days Past Due
$
2,094,819

 
$
7,337,602

91 to 180 Days Past Due
1,251,424

 
1,028,235

181 + Days Past Due
27,500

 
252,770

Total customer balances with past due amounts reclassified to trade accounts receivable
$
3,373,743

 
$
8,618,607

Total customer balances with no past due amounts reclassified to trade accounts receivable
457,671

 
4,076,185

Total financing receivables with contractual maturities of one year or less
26,744,807

 
448,487

Less allowance for losses
(1,547,889
)
 
(662,315
)
Total financing receivables
$
29,028,332

 
$
12,480,964

First Generation Meaningful Use Installment Plans
During 2012, the Company entered into multiple customer license agreements with payment terms requiring the customer to remit to the Company incentive payments (not to exceed the remaining balance of the contract price) received under the American Recovery and Reinvestment Act of 2009 (“ARRA”) for adoption of qualifying electronic health records (“EHRs”), with only nominal payment amounts required until the customer’s receipt of such incentive payments ("First Generation Meaningful Use Installment Plans"). If no such incentive payments are received by the customer or if such payments are not sufficient to pay the remaining balance under the arrangement, payments continue at contracted nominal amounts until the balance of the contract price is paid in full. Because of the significant difference in the underlying economics of these arrangements compared to our historical financing receivables, management has determined that these arrangements are not comparable to historical arrangements. In accordance with the Software topic and Revenue

16
Table of Contents

Recognition subtopic of the Codification, the Company recognizes revenue related to these arrangements as the amounts become due. Anticipated future cash flows from these 2012 licensing arrangements are excluded from the Company’s financing receivables and deferred revenue in the accompanying Condensed Consolidated Balance Sheets. Direct, incremental costs in the amount of $339,688, included as a component of prepaid expenses and other in the accompanying Condensed Consolidated Balance Sheets, have been capitalized as of June 30, 2013 related to these arrangements.
Second Generation Meaningful Use Installment Plans
Beginning in the fourth quarter of 2012, we ceased offering First Generation Meaningful Use Installment Plans to our customers, opting instead for license agreements with payment terms that provide us with greater visibility into and control over the customer's meaningful use attestation process and significantly reducing the maximum timeframe over which customers must satisfy their full payment obligations in purchasing our system (“Second Generation Meaningful Use Installment Plans”). As the overall payment period durations of the Second Generation Meaningful Use Installment Plans are consistent with that of our historical system sale financing arrangements, revenues under the Second Generation Meaningful Use Installment Plans are recognized upon installation of our EHR solution. Consistent with the terms of the respective agreements, all related amounts are included as a component of financing receivables, current portion, net in the accompanying Condensed Consolidated Balance Sheets and as a component of short-term payment plans within this Note 8.
Nearly all of our new system installations during the six months ended June 30, 2013 were under Second Generation Meaningful Use Installment Plans, resulting in a significant increase in our financing receivables balance related to short-term payment plans from December 31, 2012 to June 30, 2013. Consequently, this concentration of system installations under short-term payment plans has resulted in the overall significant decrease in amounts due under sales-type leases from December 31, 2012 to June 30, 2013.
9.     COMMITMENTS AND CONTINGENCIES
From time to time, the Company is involved in routine litigation that arises in the ordinary course of business. Management does not expect this to have a material adverse effect on the Company’s financial statements.
10.     FAIR VALUE
FASB Codification topic, Fair Value Measurements and Disclosures, establishes a framework for measuring fair value and expands financial statement disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The Codification does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. The Codification requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs that are not corroborated by market data.
The fair values of the Company’s available-for-sale securities are based on matrix pricing for the periods ended June 30, 2013 and December 31, 2012, which uses observable market-based inputs (such as benchmark yields) in addition to quoted prices in active markets to derive fair values. As a result, these inputs are classified as Level 2 within the fair value hierarchy. We generally apply fair value techniques on a non-recurring basis associated with (1) valuing potential impairment loss related to financing receivables accounted for pursuant to Codification topic, Leases, and (2) valuing potential impairment loss related to long-lived assets accounted for pursuant to Codification topic, Property, Plant and Equipment, when events or circumstances indicate a possible impairment.

17
Table of Contents

The following tables summarize the carrying amounts and fair values of certain assets and liabilities at June 30, 2013 and December 31, 2012:
 
 
 
Fair Value at June 30, 2013 Using
 
 
 
Quoted Prices in
 
 
 
 
 
Carrying
 
Active Markets for
 
Significant Other
 
Significant
 
Amount at
 
Identical Assets
 
Observable Inputs
 
Unobservable Inputs
 
6/30/2013
 
(Level 1)
 
(Level 2)
 
(Level 3)
Description
 
 
 
 
 
 
 
Available-for-sale securities
 
 
 
 
 
 
 
Short-term investments (cash and accrued income)
$
2,139,002

 
$
—

 
$
2,139,002

 
$
—

Mortgage backed securities
87,560

 
—

 
87,560

 
—

Obligations of U.S. Treasury, U.S. government corporations and agencies
3,299,314

 
—

 
3,299,314

 
—

Corporate bonds
5,160,363

 
—

 
5,160,363

 
—

Total available-for-sale securities
$
10,686,239

 
$
—

 
$
10,686,239

 
$
—


 
 
 
 
Fair Value at December 31, 2012 Using
 
 
 
Quoted Prices in
 
 
 
 
 
Carrying
 
Active Markets for
 
Significant Other
 
Significant
 
Amount at
 
Identical Assets
 
Observable Inputs
 
Unobservable Inputs
 
12/31/2012
 
(Level 1)
 
(Level 2)
 
(Level 3)
Description
 
 
 
 
 
 
 
Available-for-sale securities
 
 
 
 
 
 
 
Short-term investments (cash and accrued income)
$
449,420

 
$
—

 
$
449,420

 
$
—

Mortgage backed securities
95,604

 
—

 
95,604

 
—

Obligations of U.S. Treasury, U.S. government corporations and agencies
2,381,779

 
—

 
2,381,779

 
—

Corporate bonds
7,747,806

 
—

 
7,747,806

 
—

Total available-for-sale securities
$
10,674,609

 
$
—

 
$
10,674,609

 
$
—

Accrued income in the above tables represents earnings due and payable to our investment portfolio at any point in time but not yet received.
The carrying amount of other financial instruments reported in the balance sheet for current assets and current liabilities approximate their fair values because of the short-term nature of these instruments.
11.     RECENT ACCOUNTING PRONOUNCEMENTS
New Accounting Standards Adopted in 2013
There were no new standards required to be adopted during the six months ended June 30, 2013 that will have a material impact on our financial statements.
New Accounting Standards Yet to be Adopted
There are no new standards required to be adopted in future periods that will have a material impact on our financial statements.

18
Table of Contents

12.     SUBSEQUENT EVENTS
On July 25, 2013, the Company announced a dividend for the third quarter of 2013 in the amount of $0.51 per share, payable on August 23, 2013, to stockholders of record as of the close of business on August 8, 2013.

19
Table of Contents

Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
You should read the following discussion and analysis of our financial condition and results of operations together with the unaudited condensed consolidated financial statements and related notes appearing elsewhere herein.
This discussion and analysis contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified generally by the use of forward-looking terminology and words such as “expects,” “anticipates,” “estimates,” “believes,” “predicts,” “intends,” “plans,” “potential,” “may,” “continue,” “should,” “will” and words of comparable meaning. Without limiting the generality of the preceding statement, all statements in this report relating to estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates and future financial results are forward-looking statements. We caution investors that any such forward-looking statements are only predictions and are not guarantees of future performance. Certain risks, uncertainties and other factors may cause actual results to differ materially from those projected in the forward-looking statements. Such factors may include:
•
overall business and economic conditions affecting the healthcare industry;
•
government regulation of the healthcare and health insurance industries;
•
government regulation of our products and customers, including changes in healthcare policy affecting Medicare and Medicaid reimbursement rates and qualifying technological standards;
•
potential effects of the federal health care reform legislation enacted in 2010, and implementing regulations, on the businesses of our hospital customers;
•
funding uncertainties associated with, and potential expenditures required by, the American Recovery and Reinvestment Act of 2009 in connection with the adoption of electronic health records;
•
saturation of our target market and hospital consolidations;
•
changes in customer purchasing priorities, capital expenditures and demand for information technology systems;
•
competition with companies that have greater financial, technical and marketing resources than we have;
•
failure to develop new technology and products in response to market demands;
•
fluctuations in quarterly financial performance due to, among other factors, timing of customer installations;
•
failure of our products to function properly resulting in claims for medical losses;
•
changes in accounting principles generally accepted in the United States of America;
•
breaches of security and viruses in our systems resulting in customer claims against us and harm to our reputation;
•
potential intellectual property claims against us;
•
general economic conditions, including changes in the financial and credit markets that may affect the availability and cost of credit to us or our customers; and
•
interruptions in our power supply and/or telecommunications capabilities.
Additional information concerning these and other factors which could cause differences between forward-looking statements and future actual results is discussed under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2012, as filed with the Securities and Exchange Commission.
Background
CPSI was founded in 1979 and specializes in delivering comprehensive healthcare information systems and related services to rural and community hospitals. Our systems and services are designed to support the primary functional areas of a hospital and to enhance access to necessary financial and clinical information. Our comprehensive system enables healthcare providers to improve clinical, financial and administrative outcomes. Our products and services provide solutions in key areas, including patient management, financial management, patient care and clinical, enterprise and office automation. In addition to

20
Table of Contents

servicing small- to medium-sized hospitals, we provide information technology services to other related entities in the healthcare industry, such as nursing homes, home health agencies and physician clinics.
We sell a fully integrated, enterprise-wide financial and clinical hospital information system comprised of all necessary software, hardware, peripherals, forms and office supplies, together with comprehensive customer service and support. We also offer business management, consulting and managed information technology ("IT") services, including electronic billing submissions, patient statement processing and accounts receivable management, as part of our overall information system solution. We believe that as our customer base grows, the demand for our business management, consulting and managed IT services will also continue to grow, supporting further increases in recurring revenues.
Our system currently is installed and operating in over 650 hospitals in 45 states and the District of Columbia. Our customers consist of community hospitals with 300 or fewer beds, with hospitals having 100 or fewer acute care beds comprising approximately 94% of our customers.
Management Overview
Historically we have primarily sought revenue growth through sales of healthcare information technology systems and related services to existing and new customers within our historic target market. Our strategy has produced consistent revenue growth over the long-term, as reflected in five- and ten-year compounded annual growth rates in revenues of approximately 10.8% and 9.5%, respectively, as of the end of our most recently completed fiscal year. Selling new and additional products and services to our existing customer base is an important part of CPSI’s future revenue growth. We believe that as our customer base grows, the demand for additional products and services, including business management services, will also continue to grow, supporting further increases in recurring revenues. We also expect to drive revenue growth from new product development that we may generate from our research and development activities.
In January 2013, we announced the formation of TruBridge, LLC ("TruBridge"), a wholly-owned subsidiary of CPSI. TruBridge provides the business management, consulting and managed IT services that historically had been provided by CPSI, with the expectation of expanding both our service offerings and our footprint in this particular marketplace in the future. We expect this strategic initiative to allow us to more fully take advantage of the market opportunities in providing such services by facilitating the expansion of our target market to include the entire rural and community hospital market, no longer limiting the market for our services to hospitals where CPSI already serves as the primary IT vendor.
In addition to revenue growth, our business model is focused on earnings growth. Once a hospital has installed our system, we continue to provide support and maintenance services to the customer on an ongoing basis. These services are typically provided by the same personnel who perform our system installations but at a reduced cost to us, and therefore at an increased gross margin. We also look to increase margins through cost containment measures where appropriate.
As a result of the recent economic recession, continued economic uncertainty and tightened lending standards, hospitals have experienced reduced availability of third party credit and an overall reduction in their investment portfolios. In addition, healthcare organizations with a large dependency on Medicare and Medicaid populations, such as community-based hospitals, have been impacted by the challenging financial condition of the federal government and many state governments and government programs. Accordingly, we recognize that prospective hospital customers often do not have the necessary capital to make investments in information technology. Additionally, in response to these challenges, hospitals have become more selective regarding where they invest capital, resulting in a focus on strategic spending that generates a return on their investment. Despite the current economic environment, we believe healthcare information technology is often viewed as more strategic to hospitals than other possible purchases because the technology offers the possibility of a quick return on investment. Information technology also plays an important role in healthcare by improving safety and efficiency and reducing cost. Additionally, we believe most hospitals recognize that they must invest in healthcare information technology to meet current and future regulatory, compliance and government reimbursement requirements.
Over the past five years, we have experienced an increase in customers seeking financing arrangements from us for system installations as a result of ongoing challenging economic conditions and tightened lending standards. Additionally, as our new system installation customer base expects significant future cash inflows in the form of EHR incentive payments from the federal and state governments, we have experienced a significant demand for financing arrangements allowing new system installation customers to minimize the near-term impact on their current cash resources. As a result, we have experienced a significant increase in financing arrangements that allow customers to utilize anticipated cash inflows under the EHR incentive programs in satisfaction of their payment obligations in purchasing our EHR solution. The increased demand for financing arrangements has resulted in nearly all of our new system installation customers seeking and receiving financing arrangements during the first half of 2013. Historically, we have made financing arrangements available to customers on a case-by-case basis depending upon various aspects of the proposed contract and customer attributes. These financing arrangements include short-term payment plans, longer-term lease financing through us or third-party financing companies, and Software as a Service

21
Table of Contents

(SaaS) arrangements. We intend to continue to work with prospective customers to provide for financing arrangements to purchase our systems so long as such arrangements do not adversely affect our financial position or liquidity. We believe that meeting the financial needs of community-based hospitals while allowing for the profitable expansion of our footprint in this market will remain both an opportunity and a challenge for us in the foreseeable future.
Despite the ongoing challenging economic conditions generally, including continued tightened lending standards, we have not experienced a decline in demand for our products and services and our collections of receivables remain consistent with historical trends.
American Recovery and Reinvestment Act of 2009
While the ongoing challenging economic conditions and tightened lending standards have impacted and could continue to impact the rural and community hospitals that comprise our target market, we believe that the American Recovery and Reinvestment Act of 2009 (the "ARRA") has increased and will continue to increase demand for healthcare information technology and will have a positive impact on our business prospects through 2015. The ARRA includes more than $19 billion in funding to aid healthcare organizations in modernizing their operations through the acquisition and wide-spread use of healthcare information technology. Included in the funding is approximately $17.2 billion in incentives through Medicare and Medicaid reimbursement systems to encourage and assist healthcare providers in adopting and using electronic health records ("EHR"). These incentive payments began in 2011, but if an eligible healthcare provider does not begin to demonstrate meaningful use of EHRs by October 1, 2015, then reimbursement under Medicare will begin to be reduced. Our hospital customers began receiving these incentive payments under the ARRA in 2011. As of the date of this filing, approximately 337 of our hospital customers had received payments for EHR adoption totaling nearly $333 million.
We have been focused on ensuring that we take the necessary steps to meet the needs of rural and community hospitals to help them gain access to the incentives made available under the ARRA. Primary among those steps is ensuring that our technology meets the ARRA’s EHR certification requirements. During 2010, both our hospital and medical practice EHR solutions were certified as a complete EHR by CCHIT®. Receiving this certification for both our hospital and medical practice EHR products ensures that both hospitals and providers using our EHR systems can attain “meaningful use” of EHRs and qualify for certain EHR incentives. Continuing this focus on ensuring that our technology meets the ARRA's EHR certification requirements, in July 2013 we announced that Version 19 of our hospital EHR system was certified by CCHIT® as a complete EHR in compliance with the Office of the National Coordinator for Health Information Technology ("ONC") 2014 Edition criteria. The ONC 2014 Edition criteria support both stage one and stage two meaningful use measures required to qualify eligible providers and hospitals for funding under the ARRA.
According to data reported by the ONC, along with the Centers for Medicare and Medicaid Services, as of May 2013 CPSI is third among all vendors in terms of the number of successful hospital customer attestations for complete EHR systems. As a result of our obtaining the CCHIT® certification and our track record with our hospital customers successfully achieving meaningful use, the ARRA has had and should continue to have a positive impact on our business and the businesses of the rural and community hospitals that comprise our target market.
Health Care Reform
In March 2010, President Obama signed into law the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010, collectively referred to as the “Health Reform Laws.” This sweeping legislation implements changes to the healthcare and health insurance industries from 2010 through 2015, with the ultimate goal of requiring substantially all U.S. citizens and legal residents to have qualifying health insurance coverage by 2014 and providing the means by which it will be made available to them. We anticipate that the Health Reform Laws will have little direct impact on our internal operation but may have a significant impact on the businesses of our hospital customers once fully in effect. We have not been able to determine at this point whether the impact will be positive, negative or neutral; however, it is likely that the Health Reform Laws will affect hospitals differently depending upon the populations they service. Rural and community hospitals typically service higher uninsured populations than larger urban hospitals and rely more heavily on Medicare and Medicaid for reimbursement. It remains to be seen whether the increase in the insured populations for rural and community hospitals, as well as the increase in Medicare and Medicaid reimbursements under ARRA for hospitals that implement EHR technology, will be enough to offset cuts in Medicare and Medicaid reimbursements contained in the Health Reform Laws.
We believe healthcare initiatives will continue during the foreseeable future. If adopted, some aspects of previously proposed reforms, such as further reductions in Medicare and Medicaid payments, could adversely affect the businesses of our customers and thereby harm our business.

22
Table of Contents

Deficit Reduction/Sequestration
President Obama signed legislation in August 2011, the Budget Control Act of 2011, to increase the U.S. debt ceiling. This legislation mandates significant cuts in federal spending over the next decade, as the special bipartisan Congressional committee appointed under the legislation failed to take any action on deficit reduction. Although Medicaid is specifically exempted from the federal spending cuts mandated by the legislation, it calls for a reduction of up to 2% in federal Medicare spending, all of which will be achieved by reduced reimbursements to healthcare providers. With the passage of the American Taxpayer Relief Act of 2012, the reduced reimbursements provided for under the Budget Control Act took effect starting on March 1, 2013. As our hospital customers rely heavily on reimbursements from Medicare to fund their operations, the anticipated reduction in reimbursement rates, although capped at 2%, could negatively affect the businesses of our customers and our business.
As the federal government seeks in the future to further limit deficit spending due to fiscal restraints, it will likely continue to cut entitlement spending programs such as Medicare and Medicaid matching grants which will place further cost pressures on hospitals and other healthcare providers. Furthermore, federal and state budget shortfalls could lead to potential reductions in funding for Medicare and Medicaid. Reductions in reimbursements from Medicare and Medicaid could lead to hospitals postponing expenditures on information technology.
Results of Operations
During the six months ended June 30, 2013, we generated revenues of $102.8 million from the sale of our products and services, as compared to $90.2 million in the six months ended June 30, 2012, an increase of 14.0% that can mostly be attributed to our discontinued use of First Generation Meaningful Use Installment Plans (as discussed below). We installed our core financial and patient accounting system in 17 new hospitals in the first six months of 2013 compared to 18 in the first six months of 2012. Additionally, our expanding customer base resulted in continued growth in support and maintenance revenues and business management, consulting and managed IT services revenues. Our net income for the six months ended June 30, 2013 increased 10.9% from the first six months of 2012, while cash flow from operations decreased 41.3%, primarily as a result of increases in our financing receivables.
As mentioned above, our operations have been significantly affected by the EHR incentives offered under the ARRA and the related reduction in Medicare reimbursement rates for those providers that fail to demonstrate meaningful use of EHR by October 1, 2014. "Meaningful use" of EHR under the ARRA refers to a set of core criteria that medical providers must meet in order to prove that they are using their EHR as an effective tool in their practice, plus additional a la carte menu items. Meaningful use is measured in three stages over five years, with each stage representing a level of adoption of EHR. EHR incentive payments to eligible hospitals meeting the stage one criteria began in 2011 and are scheduled to begin decreasing in October 2013. To achieve the stage one criteria, eligible hospitals are required to meet 14 core objectives and five menu objectives that they select from a total list of 10. Stage two criteria, published in September 2012, will be effective at the beginning of the federal government's fiscal year 2014 and will require eligible hospitals to meet 16 core objectives and three menu objectives to be selected from a total list of six. Most of the stage one objectives will be core objectives under stage two, and the threshold that providers must meet for these objectives for stage two has been raised.
In the first year of participation in the EHR incentive program, eligible hospitals are required to report compliance with stage one requirements for a consecutive 90-day period during the federal government's fiscal year to qualify for incentive payments. For subsequent years, the original rules required eligible hospitals to demonstrate meaningful use for a full EHR reporting year. However, for fiscal 2014 CMS is permitting a one-time three-month reporting period to allow providers time to adopt 2014 certified EHR technology. For eligible hospitals, this three-month reporting period is fixed to the quarter of the federal government's fiscal year. As a result of the required deadlines associated with these compliance periods, in order for eligible hospitals to maximize potential EHR incentive payments and escape the aforementioned reduction in Medicare reimbursement rates for failure demonstrate meaningful use of EHR by October 1, 2014, our financial results have become and will remain uneven during the term of the ARRA program, with system sales activity relating to ARRA likely being higher in the first two quarters of our fiscal year and lower in the last two quarters of our fiscal year. However, based on factors such as those presented below, our recognition of revenue for the remainder of 2013 may not be in a pattern consistent with changes in system sales activity.
During 2012, we included language in certain of our customer license agreements that more evenly matched customers’ anticipated cash inflows under the EHR incentive program with the necessary cash outflows for purchasing our EHR solution (“First Generation Meaningful Use Installment Plans”, previously referred to as "Extended Meaningful Use Installment Plans" in our prior filings with the Securities and Exchange Commission). Under these arrangements, a customer is required to remit to us incentive payments (not to exceed the remaining balance under the arrangement) received for adoption of qualifying EHRs upon receipt of such funds, with only nominal payments required until the customer’s receipt of such incentive

23
Table of Contents

payments. If no such incentive payments are received by the customer or if such payments are not sufficient to pay the remaining balance under the arrangement, payments continue at contracted nominal amounts until the balance of the contract price is paid in full. EHR incentive payments aside, these nominal payment amounts would result in the overall duration of the payment periods significantly exceeding that of our historical financing arrangements. As a result, revenue from these arrangements is recognized as the amounts become due. As of June 30, 2013, we have remaining accumulated unrecognized revenue of $3.8 million to be recognized as the amounts become due under these contracts. Of the customers contributing to the $3.8 million in accumulated unrecognized revenue as of June 30, 2013, over half have attested to stage one of meaningful use as of the date of this filing, with each of those customers attesting to stage one having already received related Medicaid incentive payments. Medicare payments, which are typically significantly larger than the related Medicaid payments, are still pending for most of these customers. Our experience suggests an average time from successful attestation in stage one to receipt of funds from Medicare under the EHR incentive program of approximately six weeks. Overall with respect to these contracts, we typically experience a timeframe of 6 to 12 months from the date of installation to receipt of funds under the EHR incentive program. The final new system installation under a First Generation Meaningful Use Installment Plan was performed during the fourth quarter of 2012, and the Company does not expect to offer such payment terms going forward. As a result, aside from the anticipated recognition of the $3.8 million of accumulated unrecognized revenue as of June 30, 2013, we do not expect First Generation Meaningful Use Installment Plans to have a significant impact on our future financial statements.
Beginning in the fourth quarter of 2012, we ceased offering First Generation Meaningful Use Installment Plans to our customers, opting instead for license agreements with payment terms that provide us with greater visibility into and control over the customer's meaningful use attestation process and significantly reducing the maximum timeframe over which customers must satisfy their full payment obligations in purchasing our system (“Second Generation Meaningful Use Installment Plans”). As the overall payment period durations of the Second Generation Meaningful Use Installment Plans are consistent with that of our historical system sale financing arrangements, revenues under the Second Generation Meaningful Use Installment Plans are recognized upon installation of our EHR solution. Nearly all of our new system installations during the six months ended June 30, 2013 have been under Second Generation Meaningful Use Installment Plans, resulting in a significant increase in our financing receivables balances from December 31, 2012 to June 30, 2013. We expect the trend towards increased financing arrangements (predominantly through Second Generation Meaningful Use Installment Plans) to continue for the next few years.

24
Table of Contents

The following table sets forth certain items included in our results of operations for the three and six months ended June 30, 2013 and 2012, expressed as a percentage of our total revenues for these periods (dollar amounts in thousands):
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2013
 
2012
 
2013
 
2012
 
Amount
 
% Sales
 
Amount
 
% Sales
 
Amount
 
% Sales
 
Amount
 
% Sales
INCOME DATA:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sales revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
System sales
$
22,377

 
42.0
%
 
$
17,829

 
39.0
%
 
$
43,099

 
41.9
%
 
$
34,903

 
38.7
%
Support and maintenance (1)
17,738

 
33.3
%
 
16,879

 
36.9
%
 
35,415

 
34.4
%
 
33,545

 
37.2
%
Business management, consulting and managed IT services (1)
13,147

 
24.7
%
 
11,024

 
24.1
%
 
24,296

 
23.6
%
 
21,773

 
24.1
%
Total sales revenues
53,262

 
100.0
%
 
45,732

 
100.0
%
 
102,810

 
100.0
%
 
90,221

 
100.0
%
Costs of sales:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
System sales
13,083

 
24.6
%
 
12,679

 
27.7
%
 
26,334

 
25.6
%
 
24,579

 
27.2
%
Support and maintenance (1)
7,160

 
13.4
%
 
6,660

 
14.6
%
 
14,413

 
14.0
%
 
13,526

 
15.0
%
Business management, consulting and managed IT services (1)
7,541

 
14.2
%
 
6,254

 
13.7
%
 
14,467

 
14.1
%
 
12,710

 
14.1
%
Total costs of sales
27,784

 
52.2
%
 
25,593

 
56.0
%
 
55,214

 
53.7
%
 
50,815

 
56.3
%
Gross profit
25,478

 
47.8
%
 
20,139

 
44.0
%
 
47,596

 
46.3
%
 
39,406

 
43.7
%
Operating expenses:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sales and marketing
4,135

 
7.8
%
 
3,641

 
8.0
%
 
7,711

 
7.5
%
 
7,281

 
8.1
%
General and administrative
8,194

 
15.4
%
 
6,573

 
14.4
%
 
16,628

 
16.2
%
 
13,200

 
14.6
%
Total operating expenses
12,329

 
23.1
%
 
10,214

 
22.3
%
 
24,339

 
23.7
%
 
20,481

 
22.7
%
Operating income
13,149

 
24.7
%
 
9,925

 
21.7
%
 
23,257

 
22.6
%
 
18,925

 
21.0
%
Other income:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest income
137

 
0.3
%
 
189

 
0.4
%
 
273

 
0.3
%
 
348

 
0.4
%
Total other income
137

 
0.3
%
 
189

 
0.4
%
 
273

 
0.3
%
 
348

 
0.4
%
Income before taxes
13,286

 
24.9
%
 
10,114

 
22.1
%
 
23,530

 
22.9
%
 
19,273

 
21.4
%
Income taxes
4,800

 
9.0
%
 
1,853

 
4.1
%
 
8,101

 
7.9
%
 
5,363

 
5.9
%
Net income
$
8,486

 
15.9
%
 
$
8,261

 
18.1
%
 
$
15,429

 
15.0
%
 
$
13,910

 
15.4
%
(1) Prior year amounts have been reclassified to reflect the current presentation. See Note 1 to the condensed consolidated financial statements, included herein.
Three Months Ended June 30, 2013 Compared with Three Months Ended June 30, 2012
Revenues. Total revenues for the three months ended June 30, 2013 increased 16.5%, or $7.5 million, compared to the three months ended June 30, 2012. This was largely attributable to an increase in system sales revenues, primarily caused by an increase in new system installations under Second Generation Meaningful Use Installment Plans combined with revenue recognized related to First Generation Meaningful Use Installment Plans of $1.0 million (net of approximately $0.1 million of additional unrecognized revenue accumulated during the three months ended June 30, 2013 related to these arrangements). Additionally, we experienced an increase in support and maintenance revenues and business management, consulting and managed IT services revenues due to a larger customer base and increased applications within that customer base requiring support and maintenance services, as well as increased demand and market acceptance of our business management, consulting and managed IT services.
System sales revenues increased by 25.5%, or $4.5 million, for the comparative three-month periods. We completed financial and patient software system installations at ten new hospital clients in the second quarter of 2013 (none of which was under a First Generation Meaningful Use Installment Plan) compared to nine in the second quarter of 2012 (four of which were under First Generation Meaningful Use Installment Plans). Sales to existing customers accounted for 43.1% of our system sales revenues for the second quarter of 2013 compared to 71.9% for the second quarter of 2012. During the second quarter of 2012, the Company installed systems under First Generation Meaningful Use Installment Plans for which a substantial majority of the consideration is not received or revenue recognized until the customers successfully achieve "meaningful use" designation and receive related stage one ARRA incentive payments. These arrangements resulted in $4.7 million of accumulated unrecognized revenue during the second quarter of 2012 and revenue recognized (net of additional unrecognized revenue accumulated) of

25
Table of Contents

$1.0 million during the second quarter of 2013. Excluding the net effect on revenue resulting from these arrangements, adjusted system sales (as hereinafter defined in the "Non-GAAP Financial Measures" section below) decreased $1.1 million, or 4.9%, due to the significant decrease in add-on sales to existing customers.
Support and maintenance revenues increased by 5.1%, or $0.9 million, for the comparative three-month periods. Support service fees increased by 7.5%, or $1.2 million, due to an increase in recurring revenues as a result of a larger customer base, an increase in support fees for add-on business sold to existing customers, and increases in support rates from contractually agreed upon Consumer Price Index (“CPI”) rate increases. The increase in support service fees was partially offset by a 34.5%, or $0.3 million, decrease in SaaS, hosting and other fees as a result of the high volume during 2011 and 2012 of previously installed SaaS arrangements that have been converted to perpetual licenses at the customers' request.
Business management, consulting and managed IT services revenues increased by 19.3%, or $2.1 million, for the comparative three-month periods. We experienced this increase in business management, consulting and managed IT services revenues primarily as a result of growth in customer demand for accounts receivable management, clinical consulting and revenue cycle management services.
Costs of Sales. Total costs of sales increased by 8.6%, or $2.2 million, for the comparative three-month periods. As a percentage of total revenues, costs of sales decreased to 52.2% from 56.0%.
Costs of system sales increased by 3.2%, or $0.4 million, for the comparative three-month periods. The increase in costs of system sales was due to a $1.0 million increase in the cost of third party software subscriptions, partially offset by a $0.6 million decrease in travel costs. Third party software subscriptions increased as a result of our expanding customer base utilizing such subscribed third party software services, new royalty payments for newly copyrighted third party content, and certain immaterial year-to-date reclassifications recorded during the second quarter of 2013. Travel costs decreased as the Company's new system installations for the second quarter of 2013 were more heavily concentrated in the State of Alabama and adjacent states. Payroll and related costs remained relatively flat, decreasing slightly from $6.2 million for the second quarter of 2012 to $6.1 million for the second quarter of 2013. The gross margin on system sales increased to 41.5% for the three-month period ended June 30, 2013 from 28.9% in the three-month period ended June 30, 2012. Excluding the net effect on revenue resulting from First Generation Meaningful Use Installment Plans (which were used by the Company in 2012) and the deferral of the related cost of equipment, the adjusted gross margin on system sales (as hereinafter defined in the “Non-GAAP Financial Measures” section below) decreased to 39.5% in the three-month period ended June 30, 2013 from 42.4% in the three-month period ended June 30, 2012. The table below summarizes the major components of costs of system sales as a percentage of system sales revenues:
 
Three Months Ended
 
June 30, 2013
 
June 30, 2012
Payroll and related expenses
27.4
%
 
34.5
%
Travel expenses
13.7
%
 
20.3
%
Cost of equipment
7.8
%
 
9.8
%
Excluding the net effect on revenue and cost of equipment resulting from First Generation Meaningful Use Installment Plans, payroll and related expenses, travel expense, and adjusted cost of equipment (as hereinafter defined in the “Non-GAAP Financial Measures” section below) would represent 28.6%, 14.3% and 7.6%, respectively, of adjusted system sales (as hereinafter defined in the “Non-GAAP Financial Measures” section below) for the second quarter of 2013 compared to 27.3%, 16.1% and 9.0%, respectively, for the second quarter of 2012. Please see the tables set forth below under the caption “Non-GAAP Financial Measures” for a reconciliation of each of these non-GAAP financial measures to the comparable financial measure determined in accordance with generally accepted accounting principles in the United States (“GAAP”).
Cost of support and maintenance increased 7.5%, or $0.5 million, for the comparative three-month periods, primarily due to an increase in payroll and related costs of 5.7%, or $0.4 million, due to increased personnel. The gross margin on support and maintenance revenues decreased slightly to 59.6% for the three-month period ended June 30, 2013 from 60.6% for the three-month period ended June 30, 2012.
Our costs associated with business management, consulting and managed IT services increased 20.6%, or $1.3 million, for the comparative three-month periods, due primarily to an increase in payroll and related costs. The gross margin on these services decreased slightly to 42.6% for the three-month period ended June 30, 2013 from 43.3% for the three-month period ended June 30, 2012 due to the disproportionate increase in payroll and related costs versus revenues. Payroll and related expenses increased 21.7%, or $0.9 million, as a result of adding more employees during the trailing twelve months in order to support and develop our growing customer base and increase capacity in advance of anticipated future increases in demand.

26
Table of Contents

We also experienced a $0.3 million increase in related travel costs, primarily due to the increased volume of clinical consulting engagements.
Sales and Marketing Expenses. Sales and marketing expenses increased 13.6%, or $0.5 million, for the comparative three month periods. This increase was primarily attributable to increased commissions resulting from an increase in billings for system sales revenues.
General and Administrative Expenses. General and administrative expenses increased 24.7%, or $1.6 million, for the comparative three-month periods, with the largest contributing factor being a $1.2 million increase in bad debt expense due to the continued significant increase in our financing receivables balances and the write-off of significant amounts related to a single customer experiencing significant financial difficulty. Payroll and related costs increased $0.2 million, due mostly to our increased profitability during the second quarter of 2013 compared to the second quarter of 2012, resulting in a $0.2 million increase in expenses related to our incentive bonus program for certain members of management.
As a percentage of total revenues, sales and marketing expenses, and general and administrative expenses increased to 23.1% for the three-month period ended June 30, 2013 compared to 22.3% for the three-month period ended June 30, 2012.
As a result of the foregoing factors, income before taxes increased by 31.4%, or $3.2 million, from the three months ended June 30, 2012.
Income Taxes. Our effective income tax rate for the three-month periods ended June 30, 2013 and 2012 was 36.1% and 18.3%, respectively. The significant increase in our effective income tax rate is primarily due to $1.8 million of favorable provision-to-return adjustments related to our 2011 federal and state income tax returns that were recorded during the three-months ended June 30, 2012. These adjustments were primarily related to differences between the Domestic Production Activities Deduction ("DPAD") reported on the 2011 federal income tax return and amounts previously estimated.
Net Income. Net income for the three months ended June 30, 2013 increased by 2.7%, or $0.2 million, to $8.5 million, or $0.77 per basic and diluted share, as compared with net income of $8.3 million, or $0.75 per basic and diluted share, for the three months ended June 30, 2012. Net income represented 15.9% of revenue for the three months ended June 30, 2013, as compared to 18.1% of revenue for the three months ended June 30, 2012.
Six Months Ended June 30, 2013 Compared with Six Months Ended June 30, 2012
Revenues. Total revenues for the six months ended June 30, 2013 increased 14.0%, or $12.6 million, compared to the six months ended June 30, 2012. This was largely attributable to an increase in system sales revenues, primarily caused by an increase in new system installations under Second Generation Meaningful Use Installment Plans combined with revenue recognized related to First Generation Meaningful Use Installment Plans of $2.8 million (net of approximately $0.6 million of additional unrecognized revenue accumulated during the six months ended June 30, 2013 related to these arrangements). Additionally, we experienced an increase in support and maintenance revenues and business management, consulting and managed IT services revenues due to a larger customer base and increased applications within that customer base requiring support and maintenance services, as well as increased demand and market acceptance of our business management, consulting and managed IT services.
System sales revenues increased by 23.5%, or $8.2 million, for the comparative six-month periods. We completed financial and patient software system installations at 17 new hospital clients in the first six months of 2013 (none of which was under a First Generation Meaningful Use Installment Plan) compared to 18 in the first six months of 2012 (seven of which were under First Generation Meaningful Use Installment Plans). Sales to existing customers accounted for 49.3% of our system sales revenues for the first six months of 2013 compared to 74.7% for the first six months of 2012. During the first six months of 2012, the Company installed systems under First Generation Meaningful Use Installment Plans for which a substantial majority of the consideration is not received or revenue recognized until the customers successfully achieve "meaningful use" designation and receive related stage one ARRA incentive payments. These arrangements resulted in $9.8 million of accumulated unrecognized revenue during the first six months of 2012 and revenue recognized (net of additional unrecognized revenue accumulated) of $2.8 million during the first six months of 2013. Excluding the net effect on revenue resulting from these arrangements, adjusted system sales (as hereinafter defined in the "Non-GAAP Financial Measures" section below) decreased $4.4 million, or 9.9%, due to the decrease in add-on sales to existing customers.
Support and maintenance revenues increased by 5.6%, or $1.9 million, for the comparative six-month periods. Support service fees increased by 8.3%, or $2.6 million, due to an increase in recurring revenues as a result of a larger customer base, an increase in support fees for add-on business sold to existing customers, and increases in support rates from contractually agreed upon Consumer Price Index (“CPI”) rate increases. The increase in support service fees was partially offset by a 35.0%, or $0.6

27
Table of Contents

million, decrease in SaaS, hosting and other fees as a result of the high volume during 2011 and 2012 of previously installed SaaS arrangements that have been converted to perpetual licenses at the customers' request.
Business management, consulting and managed IT services revenues increased by 11.6%, or $2.5 million, for the comparative six-month periods. We experienced this increase in business management, consulting and managed IT services revenues primarily as a result of growth in customer demand for accounts receivable management, private pay, revenue cycle management and cloud computing services (a component of managed IT services).
Costs of Sales. Total costs of sales increased by 8.7%, or $4.4 million, for the comparative six-month periods. As a percentage of total revenues, costs of sales decreased to 53.7% from 56.3%.
Costs of system sales increased by 7.1%, or $1.8 million, for the comparative six-month periods. The increase in costs of system sales was primarily due to a $1.2 million increase in the cost of third party software subscriptions and a $0.3 million increase in payroll and related costs. Third party software subscriptions increased as a result of our expanding customer base utilizing such subscribed third party software services and new royalty payments for newly copyrighted third party content, and payroll and related costs increased due to increased personnel. The gross margin on system sales increased to 38.9% for the six-month period ended June 30, 2013 from 29.6% in the six-month period ended June 30, 2012. Excluding the net effect on revenue resulting from First Generation Meaningful Use Installment Plans (which were used by the Company in 2012) and the deferral of the related cost of equipment, the adjusted gross margin on system sales (as hereinafter defined in the “Non-GAAP Financial Measures” section below) decreased to 35.1% in the six-month period ended June 30, 2013 from 43.2% in the six-month period ended June 30, 2012. The table below summarizes the major components of costs of system sales as a percentage of system sales revenues:
 
Six Months Ended
 
June 30, 2013
 
June 30, 2012
Payroll and related expenses
28.8
%
 
34.7
%
Travel expenses
16.1
%
 
19.6
%
Cost of equipment
8.4
%
 
10.2
%
Excluding the net effect on revenue and cost of equipment resulting from First Generation Meaningful Use Installment Plans, payroll and related expenses, travel expense, and adjusted cost of equipment (as hereinafter defined in the “Non-GAAP Financial Measures” section below) would represent 30.8%, 17.3% and 8.5%, respectively, of adjusted system sales (as hereinafter defined in the “Non-GAAP Financial Measures” section below) for the first six months of 2013 compared to 27.1%, 15.3% and 9.8%, respectively, for the first six months of 2012. Please see the tables set forth below under the caption “Non-GAAP Financial Measures” for a reconciliation of each of these non-GAAP financial measures to the comparable financial measure determined in accordance with generally accepted accounting principles in the United States (“GAAP”).
Cost of support and maintenance increased 6.6%, or $0.9 million, for the comparative six-month periods, primarily due to an increase in payroll and related costs of 7.5%, or $0.9 million, due to increased personnel. The gross margin on support and maintenance revenues decreased slightly to 59.3% for the six-month period ended June 30, 2013 from 59.7% for the six-month period ended June 30, 2012.
Our costs associated with business management, consulting and managed IT services increased 13.8%, or $1.8 million, for the comparative six-month periods due primarily to an increase in payroll and related costs. The gross margin on these services decreased to 40.5% for the six-month period ended June 30, 2013 from 41.6% for the six-month period ended June 30, 2012 due to the disproportionate increase in payroll and related costs versus revenues. Payroll and related expenses increased 18.8%, or $1.5 million, as a result of adding more employees during the trailing twelve months in order to support and develop our growing customer base and increase capacity in advance of anticipated future increases in demand. We also experienced a $0.3 million increase in related travel costs, primarily due to the increased volume of clinical consulting engagements.
Sales and Marketing Expenses. Sales and marketing expenses increased 5.9%, or $0.4 million, for the comparative six month periods. This increase was primarily attributable to increased commissions resulting from an increase in system sales revenues.
General and Administrative Expenses. General and administrative expenses increased 26.0%, or $3.4 million, for the comparative six-month periods, with the largest contributing factor being a $1.4 million increase in bad debt expense due to the continued significant increase in our financing receivables balances and the write-off of significant amounts related to a single customer experiencing significant financial difficulty. Our group health insurance expense increased 26.0%, or $1.0 million, due to the combined factors of increased headcount and continuing increases in healthcare costs. Our expenses related to

28
Table of Contents

customer user groups increased $0.3 million as we held our Financial, Clinical, and Physician Conferences in May 2013, with no events of similar scale occurring during the six months ended June 30, 2012. Payroll and related costs increased $0.2 million, due mostly to our increased profitability during the first half of 2013 compared to the first half of 2012, resulting in a $0.2 million increase in expenses related to our incentive bonus program for certain members of management. Retirement plan costs increased $0.2 million as a result of additional personnel added over the trailing twelve months. Lastly, our depreciation expense increased $0.2 million as a result of significant capital expenditures over the trailing twelve months, mostly related to the build-out of our new facility in Fairhope, Alabama.
As a percentage of total revenues, sales and marketing expenses, and general and administrative expenses increased to 23.7% for the six-month period ended June 30, 2013 compared to 22.7% for the six-month period ended June 30, 2012.
As a result of the foregoing factors, income before taxes increased by 22.1%, or $4.3 million, from the six months ended June 30, 2012.
Income Taxes. Our effective income tax rate for the six-month periods ended June 30, 2013 and 2012 was 34.4% and 27.8%, respectively. The significant increase in our effective income tax rate is primarily due to $1.8 million of favorable provision-to-return adjustments related to our 2011 federal and state income tax returns that were recorded during the six-months ended June 30, 2012. These adjustments were primarily related to differences between the Domestic Production Activities Deduction ("DPAD") reported on the 2011 federal income tax return and amounts previously estimated.
Net Income. Net income for the six months ended June 30, 2013 increased by 10.9%, or $1.5 million, to $15.4 million, or $1.39 per basic and diluted share, as compared with net income of $13.9 million, or $1.26 per basic and diluted share, for the six months ended June 30, 2012. Net income represented 15.0% of revenue for the six months ended June 30, 2013, as compared to 15.4% of revenue for the six months ended June 30, 2012.
Liquidity and Capital Resources
As of June 30, 2013, we had cash and cash equivalents of $1.6 million, compared to $5.2 million at June 30, 2012. This decrease in cash and cash equivalents is mostly due to a significant decrease in net cash provided by operating activities, as discussed below. Management believes that cash and investments plus cash generated from our normal operating activities should be adequate to fund our business through the remainder of 2013. Our principal source of liquidity has been cash provided by operating activities. Cash provided by operating activities has been used primarily to fund the growth in our business and return cash to stockholders in the form of dividends. We believe that paying dividends is an effective way of providing an investment return to our stockholders and a beneficial use of our cash. However, the declaration of dividends by CPSI is subject to the discretion of our Board of Directors. Our Board of Directors will continue to take into account such matters as general business conditions, our financial results and such other factors as our Board of Directors may deem relevant.
Net cash provided by operating activities for the six months ended June 30, 2013 was $6.8 million, compared to $11.5 million for the six months ended June 30, 2012. This decrease in net cash provided by operating activities is despite a 10.9% increase in net income from the first six months of 2012 to the first six months of 2013 and primarily results from a significant increase in our financing receivables. We continued to experience increased levels of customers seeking financing arrangements for system installations during the year due to continued challenging economic conditions, unavailability of third-party credit, and the increasing preference by our new system installation customers to minimize the near-term impact that purchasing our system will have on their current cash resources. We expect this trend of increased levels of customers seeking financing arrangements for system installations to continue during the next twelve months, resulting in further increases in our financing receivables. The expected increase in financing receivables, although offset by periodic collections of previously outstanding amounts, could temporarily have a negative impact on our net cash provided by operating activities.
Net cash used in investing activities totaled $2.8 million for the six months ended June 30, 2013, compared to $2.7 million for the six months ended June 30, 2012. We used cash for the purchase of $2.7 million of property and equipment during the first six months of 2013, with approximately half of that amount related to the build-out of our new facility in Fairhope, Alabama. We do not anticipate the need for significant investing activities for capital expenditures during the remainder of 2013.
Net cash used in financing activities totaled $11.3 million for the six months ended June 30, 2013, compared to $10.2 million for the six months ended June 30, 2012. During the six months ended June 30, 2013, we increased our dividend rate 10.9% to $0.51 per share from $0.46 per share.
Our days sales outstanding, which represents the average collection time for accounts receivable, for the six months ended June 30, 2013 and 2012 were 35 and 43 days, respectively.

29
Table of Contents

We currently do not have a bank line of credit or other credit facility in place. Because we have no debt, we are not subject to contractual restrictions or other influences on our operations, such as payment demands and restrictions on the use of operating funds that are typically associated with debt. If we borrow money in the future, we will likely be subject to operating and financial covenants that could limit our ability to operate as profitably as we have in the past. Defaults under applicable loan agreements could result in the demand by lenders for immediate payment of substantial funds and substantial restrictions on expenditures, among other things. Due to the recent economic recession and ongoing tightened lending standards, additional capital, if needed, may not be available on terms favorable to us, or at all.
Our future capital requirements will depend upon a number of factors, including the rate of growth of our sales, cash collections from our customers and our future investments in fixed assets. We believe that our available cash and cash equivalents, investments and anticipated cash generated from operations will be sufficient to meet our operating requirements for at least the next 12 months.
Off Balance Sheet Arrangements
We had no off-balance sheet arrangements, as defined by Item 303(a)(4) of SEC Regulation S-K, as of March 31, 2013.
The Company has other lease rights and obligations that it accounts for as operating leases that may be reclassified as balance sheet arrangements under accounting pronouncements currently being considered by the Financial Accounting Standards Board ("FASB").
Critical Accounting Policies
Our Management Discussion and Analysis is based upon our Condensed Consolidated Financial Statements, which have been prepared in accordance with GAAP. The preparation of these financial statements requires us to make subjective or complex judgments that may affect the reported financial condition and results of operations. We base our estimates on historical experience and other assumptions that we believe to be reasonable in the circumstances, the results of which form the basis for making judgments about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We continually evaluate the information used to make these estimates as our business and the economic environment changes.
In our Annual Report on Form 10-K for the year ended December 31, 2012, we identified our critical accounting polices related to revenue recognition, allowance for doubtful accounts, allowance for credit losses and estimates. There have been no significant changes to these critical accounting policies for the three months ended June 30, 2013.
Non-GAAP Financial Measures
We have included in the discussion under the captions “Three Months Ended June 30, 2013 Compared with Three Months Ended June 30, 2012” and "Six Months Ended June 30, 2013 Compared with Six Months Ended June 30, 2012" above financial measures that were not prepared in accordance with GAAP. Any analysis of non-GAAP financial measures should be made only in conjunction with results presented in accordance with GAAP. Below, we define each of these non-GAAP financial measures, provide a reconciliation of each non-GAAP financial measures to the most directly comparable financial measure calculated in accordance with GAAP, and discuss the reasons that we believe this information is useful to management and may be useful to investors.
We use the non-GAAP financial measures “adjusted gross margin on system sales,” “adjusted cost of equipment,” and “adjusted system sales.” Management believes these non-GAAP financial measures provide our Board of Directors, investors, potential investors, securities analysts and others with useful information to evaluate our performance because they exclude the impact of unrecognized revenue, recognized revenue and related deferral of cost of equipment resulting from our use of First Generation Meaningful Use Installment Plans. First Generation Meaningful Use Installment Plans were new to the Company in 2012, resulting in the Company not having sufficient experience with comparable arrangements to establish evidence of a standard business practice of historically collecting under the original payment terms of such contracts without making concessions. As a result, the provisions of the Software topic and Revenue Recognition subtopic of the FASB Accounting Standards Codification result in a conclusion that the fee is not fixed or determinable and, as a result, the revenue is to be recognized as the amounts become due. Because the timing of our recognition of revenue under First Generation Meaningful Use Installment Plans is not related to any remaining obligation on the part of the Company, the Company and our Board of Directors use these non-GAAP financial measures to evaluate our performance relative to other periods. We believe that the most directly comparable GAAP measures to adjusted gross margin on system sales, adjusted cost of equipment, and adjusted system sales are gross margin on system sales, cost of equipment, and system sales, respectively. Set forth below are reconciliations of adjusted gross margin on system sales, adjusted cost of equipment, and adjusted system sales to the comparable financial measures calculated in accordance with GAAP (dollar amounts in thousands):

30
Table of Contents

Adjusted Gross Margin on System Sales
 
Three Months Ended
 
Six Months Ended
 
June 30, 2013
 
June 30, 2012
 
6/30/2013
 
6/30/2012
Gross margin on system sales
$
9,293

 
$
5,149

 
$
16,765

 
$
10,325

Add: Unrecognized revenue accumulated related to First Generation Meaningful Use Installment Plans
109

 
4,679

 
592

 
9,821

Less: Revenue recognized related to First Generation Meaningful Use Installment Plans
(1,086
)
 
—

 
(3,379
)
 
—

Less: Deferred cost of equipment related to First Generation Meaningful Use Installment Plans
—

 
(333
)
 
(9
)
 
(870
)
Add: Amortization of deferred cost of equipment related to First Generation Meaningful Use Installment Plans
136

 
54

 
190

 
54

Adjusted gross margin on system sales
$
8,452

 
$
9,549

 
$
14,159

 
$
19,330

Adjusted Cost of Equipment
 
Three Months Ended
 
Six Months Ended
 
June 30, 2013
 
June 30, 2012
 
June 30, 2013
 
June 30, 2012
Cost of equipment
$
1,755

 
$
1,748

 
$
3,614

 
$
3,547

Add: Deferred cost of equipment related to First Generation Meaningful Use Installment Plans
—

 
333

 
9

 
870

Less: Amortization of deferred cost of equipment related to First Generation Meaningful Use Installment Plans
(136
)
 
(54
)
 
(190
)
 
(54
)
Adjusted cost of equipment
$
1,619

 
$
2,027

 
$
3,433

 
$
4,363

Adjusted System Sales
 
Three Months Ended
 
Six Months Ended
 
June 30, 2013
 
June 30, 2012
 
June 30, 2013
 
June 30, 2012
System sales
$
22,377

 
$
17,829

 
$
43,099

 
$
34,903

Add: Unrecognized revenue accumulated related to First Generation Meaningful Use Installment Plans
109

 
4,679

 
592

 
9,821

Less: Revenue recognized related to First Generation Meaningful Use Installment Plans
(1,086
)
 
—

 
(3,379
)
 
—

Adjusted system sales
$
21,400

 
$
22,508

 
$
40,312

 
$
44,724

 
Item 3.
Quantitative and Qualitative Disclosures about Market Risk.
Our exposure to market risk relates primarily to the potential change in the value of our investment portfolio as a result of fluctuations in interest rates. The primary purpose of our investment activities is to preserve principal while maximizing the income we receive from our investments without significantly increasing risk of loss. As of June 30, 2013, our investment portfolio consisted of a variety of financial instruments, primarily including, but not limited to, money market securities and high quality government and corporate obligations. It is our intent to ensure the safety and preservation of our invested principal funds by limiting default risk, market risk and reinvestment risk. We do not hold financial instruments for trading or other speculative purposes. The securities in our investment portfolio are classified as available-for-sale and, consequently, are recorded on our balance sheet at fair market value with their related unrealized gain or loss reflected as a component of accumulated other comprehensive income (loss) in stockholders’ equity.

31
Table of Contents

Investments in both fixed rate and floating rate interest earning instruments carry a degree of interest rate risk. Fixed rate securities may have their fair market value adversely impacted due to a rise in interest rates, while floating rate securities may produce less income than expected if interest rates fall. Due in part to these factors, our future investment income may fall short of expectation due to changes in interest rates or we may suffer losses in principal if forced to sell securities which have declined in market value due to changes in interest rates.
We believe that the market risk arising from our holdings of these financial instruments is minimal. Due to the conservative allocation of our investment portfolio, we do not believe that an immediate 10% increase in interest rates would have a material effect on the fair market value of our portfolio. Additionally, since we believe we have the ability to liquidate this portfolio, we do not expect our operating results or cash flows to be materially affected to any significant degree by a sudden change in market interest rates on our investment portfolio. We do not utilize derivative financial instruments to manage our interest rate risks.
The table that follows presents fair values of principal amounts and weighted average interest rates for our investment portfolio as of June 30, 2013.
 
Aggregate
Fair Value
 
Weighted
Average
Interest Rate
Cash and Cash Equivalents:
 
 
 
Cash and cash equivalents
$
1,583,642

 
—
%
Short-Term Investments: (1)
 
 
 
Accrued income
$
48,095

 
—
%
Money market funds
2,090,907

 
0.08
%
Obligations of the U.S. Treasury, U.S government corporations and agencies
2,266,393

 
1.83
%
Corporate debt securities
2,721,174

 
3.38
%
Total short-term investments
$
7,126,569

 
 
Long-Term Investments: (2)
 
 
 
Obligations of the U.S. Treasury, U.S government corporations and agencies
$
1,032,921

 
0.63
%
Mortgage backed securities
87,560

 
1.75
%
Corporate debt securities
2,439,189

 
2.12
%
Total long-term investments
$
3,559,670

 
 
(1)
 Reflects instruments with a contractual maturity of less than one year.
(2)
Reflects instruments with a contractual maturity of one year or more.
As of June 30, 2013, the Company had no borrowings and, therefore, is not subject to interest rate risks related to debt instruments.
 
Item 4.
Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures that are designed to provide reasonable assurance that the information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Because of the inherent limitations to the effectiveness of any system of disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that all control issues and instances of fraud, if any, with a company have been prevented or detected on a timely basis. Even disclosure controls and procedures determined to be effective can only provide reasonable assurance that their objectives are achieved.
As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)) pursuant to Rule

32
Table of Contents

13a-15 of the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective at the reasonable assurance level.
Changes in Internal Control over Financial Reporting
There were no changes in the Company’s internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f)) during the quarter ended June 30, 2013 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.


33
Table of Contents

PART II
OTHER INFORMATION
 
Item 1.
Legal Proceedings.
From time to time, we are involved in routine litigation that arises in the ordinary course of business. We are not currently involved in any litigation that we believe could reasonably be expected to have a material adverse effect on our business, financial condition or results of operations.
 
Item 1A.
Risk Factors.
In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2012, which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem immaterial also may materially adversely affect our business, financial condition or operating results.
 
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds.
Not applicable.
 
Item 3.
Defaults Upon Senior Securities.
Not applicable.
 
Item 4.
Mine Safety Disclosures.
Not applicable.
 
Item 5.
Other Information.
None.
 
Item 6.
Exhibits.
3.1
  
Certificate of Incorporation (filed as Exhibit 3.4 to CPSI’s Registration Statement on Form S-1 (Registration No. 333-84726) and incorporated herein by reference)
 
 
3.2
  
Amended and Restated Bylaws (filed as Exhibit 3 to CPSI’s Current Report on Form 8-K dated November 14, 2012 and incorporated herein by reference)
 
 
31.1
  
Certification of the Chief Executive Officer pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
 
31.2
  
Certification of the Chief Financial Officer pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
 
32.1
  
Certifications of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
 
101
  
Interactive Data Files for CPSI’s Form 10-Q for the period ended June 30, 2013


34
Table of Contents

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
COMPUTER PROGRAMS AND SYSTEMS, INC.
 
 
 
Date: August 9, 2013
 
By:
 
/s/ J. BOYD DOUGLAS
 
 
 
 
J. Boyd Douglas
 
 
 
 
President and Chief Executive Officer
 
 
 
Date: August 9, 2013
 
By:
 
/S/ DAVID A. DYE
 
 
 
 
David A. Dye
 
 
 
 
Chief Financial Officer


35
Table of Contents

Exhibit Index
 
No.
  
Exhibit
 
 
3.1
  
Certificate of Incorporation (filed as Exhibit 3.4 to CPSI’s Registration Statement on Form S-1 (Registration No. 333-84726) and incorporated herein by reference)
 
 
3.2
  
Amended and Restated Bylaws (filed as Exhibit 3 to CPSI’s Current Report on Form 8-K dated November 14, 2012 and incorporated herein by reference)
 
 
31.1
  
Certification of the Chief Executive Officer pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
 
 
31.2
  
Certification of the Chief Financial Officer pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
 
32.1
  
Certifications of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
 
101
  
Interactive Data Files for CPSI’s Form 10-Q for the period ended June 30, 2013


36
Exhibit 31.1

CERTIFICATION

I, J. Boyd Douglas, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Computer Programs and Systems, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 9, 2013
 
 
 
/s/ J. BOYD DOUGLAS
 
 
 
 
J. Boyd Douglas
 
 
 
 
President and Chief Executive Officer
 


Exhibit 31.2

CERTIFICATION

I, David A. Dye, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Computer Programs and Systems, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 9, 2013
 
 
 
/S/ DAVID A. DYE
 
 
 
 
David A. Dye
 
 
 
 
Chief Financial Officer



Exhibit 32.1

Certification Pursuant to
18 U.S.C. Section 1350,
As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report of Computer Programs and Systems, Inc. (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), J. Boyd Douglas, President and Chief Executive Officer of the Company, and David A. Dye, Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 9, 2013
 
 
 
/s/ J. BOYD DOUGLAS
 
 
 
 
J. Boyd Douglas
 
 
 
 
President and Chief Executive Officer
 
 
 
 
 
 
 
 
 
/S/ DAVID A. DYE
 
 
 
 
David A. Dye
 
 
 
 
Chief Financial Officer